Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 12
Submit an article Journal homepage
1,852
Views
9
CrossRef citations to date
0
Altmetric
Case Report

Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review

Feng Wanga Department of Neurology, Chengdu Second People’s Hospital, Chengdu, Sichuan, China
,
Tao Xiangb Department of Rehabilitation Medicine, Chengdu Jinniu District People’s Hospital, Chengdu, Sichuan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2397-0531
ORCID Icon,
Lanying Hea Department of Neurology, Chengdu Second People’s Hospital, Chengdu, Sichuan, China
&
Jian Wanga Department of Neurology, Chengdu Second People’s Hospital, Chengdu, Sichuan, China
Pages 5529-5531 | Received 02 Jul 2021, Accepted 01 Sep 2021, Published online: 24 Sep 2021

References

  • Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373–81. doi:10.1056/nejmoa070844.
  • Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei FF, Rush B, Safirstein B, Wheeler D, Nichol KL. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184(6):665–70. doi:10.1086/323085.
  • Zhou L, Su QR, Xu Z, Feng A, Jin H, Wang SY, Feng ZJ. Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12). PLOS ONE. 2013;8(9):e73724. doi:10.1371/journal.pone.0073724.
  • Margolis KL, Poland GA, Nichol KL, David SM, Meyer JD, Korn JE, Lofgren RP. Frequency of adverse reactions after influenza vaccination. Am J Med. 1990;88(1):27–30. doi:10.1016/0002-9343(90)90123-u.
  • Papke D, McNussen PJ, Rashee M, Michael S, Tsipursky LTL. Case of unilateral optic neuropathy following influenza vaccination. Semin Ophthalmol. 2017;32(4):517–23. doi:10.3109/08820538.2015.1120758.
  • Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome. Clin Immunol. 2003;107(2):116–21. doi:10.1016/s1521-6616(03)00046-9.
  • Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. doi:10.1038/s14572-019-0079-y.
  • Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375(26):2570–81. doi:10.1016/nejmral1602678.
  • Phillips LH. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003;8(1):407–12. doi:10.1196/annals.1254.053.
  • Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB. Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg. 2000;70(1):327–34. doi:10.1212/wnl.55.1.16.
  • Auriel E, Regev K, Dori A, Karni A. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve. 2011;43(6):893–94. doi:10.1002/mus.22077.
  • Louzir B, Othmani S, Battikh R, Ben Abdelhafidh N, Bahri M, Taalouche L, Bahri M. Myasthenia after hepatitis B vaccination. Therapie. 2003;58(4):378–79. doi:10.2515/therapie:2003059.
  • Stübgen JP. Neuromuscular disorders associated with hepatitis B vaccination. J Neurol Sci. 2010;292(12):1–4. doi:10.1016/j.jns.2010.02.016.
  • Takizawa T, Kojima M, Suzuki S, Osada T, Kitagawa S, Nakahara J, Takahashi S, Suzuki N. New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review. Medicine (Baltimore). 2017;96(46):e8757. doi:10.1097/md.0000000000008757.
  • Chung JY, Lee SJ, Shin BS, Kang HG. Myasthenia gravis following human papillomavirus vaccination: a case report. BMC Neurol. 2018;18(1):222. doi:10.1186/s12883-018-1233-y.
  • Yang X, Niu L, Yang C, Wang L, Liu JX. Clinical features of laryngeal myasthenia gravis: a case series. Am J Otolaryngol Head Neck Med Surg. 2019;40(2):292–96. doi:10.1016/j.amjoto.2018011.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.